Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
Recruiting
N/A
Interventional Study
Cholangiocarcinoma
Multiple Myeloma
Colon Cancer
Rectal Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 990 (estimated)
- Sponsor
- Washington University School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study wil…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Eligibility Criteria:
* Patients with cholangiocarcinoma, multiple myeloma, or early onset colon or rectal cancer.
* If diagnosed with multiple myeloma, must be African-American.
* If diagnosed with colon or rectal cancer, must be African-American AND must be no older than 65 years old at the …
Contacts